Please login to the form below

Not currently logged in
Email:
Password:

R&D news in brief

Our weekly round-up of the R&D news in brief

Call for H5N1 data network
A group of 70 scientists and health officials involved in the research of avian flu have proposed the formation of a global consortium to facilitate the sharing of genetic data related to the H5N1 virus. In a letter published in Nature, the Global Initiative on Sharing Avian Influenza Data (GISAID) said ìthe current level of collection and sharing of data is inadequate, given the magnitude of the threatî. They also said that member scientists would agree to share sequence data, jointly analyse information and publish the results collaboratively.

Rituxan shows promise in MS trial
Genentech and Biogen Idec's cancer drug, Rituxan, has shown evidence of effectiveness against multiple sclerosis in a small phase II study. In the study of 104 patients, those receiving Rituxan showed a statistically significant reduction in the number of brain lesions seen on MRI scans at weeks 12, 16, 20 and 24, compared with those receiving placebo. The two firms said they would continue to analyse the results and will submit the data for presentation at a coming medical meeting.

Stem cell extraction breakthrough
Researchers at biotechnology firm, Advanced Cell Technology, say they have developed a new way of producing stem cells that ultimately may not require the destruction of human embryos. In experiments conducted with single cells extracted from tiny human embryos, by culturing the extracted cells in the right way, the team were able to encourage them into developing as stem cells. The researchers say the new method means new lines could be derived by simply extracting a single cell from an early-stage embryo.

30th September 2008

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
certain health

Transforming the way health brands and companies communicate, we deliver creative science led, insight-driven solutions that give award winning results...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...

Infographics